FY2023 EPS Estimates for Reviva Pharmaceuticals Holdings, In

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Free Report) – Equities researchers at Zacks Small Cap lowered their FY2023 EPS estimates for Reviva Pharmaceuticals in a research note issued to investors on Monday, November 20th. Zacks Small Cap analyst J. Vandermosten now forecasts that the company will post earnings per share of ($1.43) for the year, […]

Related Keywords

Roth Mkm , Reviva Pharmaceuticals Company Profile , Reviva Pharmaceuticals Trading , Reviva Pharmaceuticals , Nasdaq , Wells Fargo Company , Institutional Trading Of Reviva Pharmaceuticals , Tower Research Capital , Reviva Pharmaceuticals Holdings Inc , Colony Group , Capital Partners , News Ratings For Reviva Pharmaceuticals Daily , Reviva Pharmaceuticals Holdings , Free Report , Zacks Small Cap , Small Cap , Reviva Pharmaceutical , Research Capital , Get Free Report , Pharmaceuticals Holdings , Reviva Pharmaceuticals Daily , Nasdaq Rvph , Rvph , Medical , Earnings Estimates ,